Informational Needs of Head and Neck Cancer Patients.
Health Technol (Berl)., Apr;2(1):57-62 (2012)
Unilateral neck therapy in the human papillomavirus ERA: Accepted regional spread patterns.
Head Neck., Feb (2012)
Increased recurrences using intensity-modulated radiation therapy in the postoperative setting.
Am. J. Clin. Oncol., Dec;33(6):599-603 (2010)
Surgery in the multimodality treatment of sinonasal malignancies.
Curr Probl Cancer., 34(5):304-21 (2010 Sep-Oct)
Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer.
Int. J. Radiat. Oncol. Biol. Phys., Jan;79(1):65-70 (2011)
Impact of neck dissection on long-term feeding tube dependence in patients with head and neck cancer treated with primary radiation or chemoradiation.
Head Neck., Mar;32(3):341-7 (2010)
Multimodal treatment for head and neck cancer.
Surg. Clin. North Am., Feb;89(1):43-52, viii (2009)
Controversies in surgical management of the node-positive neck after chemoradiation.
Semin Radiat Oncol., Jan;19(1):24-8 (2009)
Postradiotherapy neck dissection for head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis.
Head Neck., Mar;31(3):328-37 (2009)
Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
Clin. Cancer Res., Sep;12(17):5064-73 (2006)
Targeting growth factor receptors: integration of novel therapeutics in the management of head and neck cancer.
Curr Opin Oncol., May;13(3):168-75 (2001)
TGF-alpha antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo.
Gene Ther., Nov;7(22):1906-14 (2000)
An allelotype of papillary thyroid cancer.
Int. J. Cancer., Dec;69(6):442-4 (1996)